Chemical Structure : BT-13
CAS No.: 924537-98-4
Catalog No.: PC-61589Not For Human Use, Lab Use Only.
RET agonist BT13 is a novel small molecule GDNF receptor RET agonist, potently and selectively activates RET and its downstream intracellular signaling cascades in immortalized cells (EC50~20 uM).
Packing | Price | Stock | Quantity |
---|---|---|---|
5 mg | $138 | In stock | |
10 mg | $218 | In stock | |
25 mg | $358 | In stock | |
50 mg | $558 | In stock | |
100 mg | Get quote |
Bulk size, bulk discount!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
RET agonist BT13 (BT-13) is a novel small molecule GDNF receptor RET agonist, potently and selectively activates RET and its downstream intracellular signaling cascades in immortalized cells (EC50~20 uM)>
RET agonist BT13 promotes neurite outgrowth from cultured dorsal root ganglia (DRG) sensory neurons in vitro.
RET agonist BT13 alleviates mechanical hypersensitivity and reverses injury-induced changes in protein expression in DRG neurons in rat model of neuropathic pain.
M.Wt | 517.54 | |
Formula | C23H27F4N3O4S | |
Appearance | Solid | |
Storage |
|
|
Solubility |
10 mM in DMSO |
|
Chemical Name/SMILES |
N,N-diethyl-3-(4-(4-fluoro-2-(trifluoromethyl)benzoyl)piperazin-1-yl)-4-methoxybenzenesulfonamide |
1. Sidorova YA, et al. Front Pharmacol. 2017 Jun 21;8:365.
Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright